10x Genomics is trading at $93.39, up 5.22%, with no clear company-specific catalyst identified for the move. - No 10x Genomics-specific catalyst dated October 2 was found; a recent Argus Buy initiation was reported earlier but does not establish the reason. - Reuters reported U.S. futures advanced as Treasury yields retreated and investors weighed the September jobs report, consistent with a wider risk-on backdrop. - Trading is live; volume or activity-level data was not provided.